Acute intermittent porphyria, givosiran, and homocysteine-Reference-Cited by-同舟云学术

Acute intermittent porphyria, givosiran, and homocysteine

Published:2021-06-22 Issue:4 Volume:44 Page:790-791
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:Jrnl of Inher Metab Disea

Author:

Fontanellas Antonio¹²³^ORCID,Ávila Matías A.¹²³,Arranz Elena⁴,Enríquez de Salamanca Rafael⁴,Morales‐Conejo Montserrat⁴⁵

Affiliation:

1. Hepatology Program Cima Universidad de Navarra Pamplona Spain

2. Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona Spain

3. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) Instituto de Salud Carlos III Madrid Spain

4. Reference Center for Inherited Metabolic Disease—MetabERN, Department of Internal Medicine University Hospital 12 de Octubre, UCM Madrid Spain

5. Grupo de Enfermedades Mitocondriales y Neuromusculares, Instituto de Investigación Hospital 12 de Octubre (i+12) Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) Madrid Spain

Funder

Fundación Mutua Madrileña

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jimd.12411

Reference4 articles.

1. Preliminary report: Hyperhomocysteinemia in patients with acute intermittent porphyria

2. Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad?

3. Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran

4. S‐Adenosylmethionine: a control switch that regulates liver function

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventing hyperhomocysteinemia using vitamin B6 supplementation in Givosiran-treated acute intermittent porphyria: Highlights from a case report and brief literature review;Molecular Genetics and Metabolism Reports;2024-06

2. Exploring current and emerging therapies for porphyrias;Liver International;2024-05-30

3. Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis;Hepatology Communications;2023-12

4. Complicaciones a largo plazo de las porfirias hepáticas agudas;Medicina Clínica;2023-09

5. Diagnóstico, evaluación y seguimiento de la porfiria hepática aguda;Medicina Clínica;2023-09